Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan

被引：0
|
作者：
Eleonora M. de Leede
Mark C. Burgmans
T. Susanna Meijer
Christian H. Martini
Fred G. J. Tijl
Jaap Vuyk
Arian R. van Erkel
Cornelis J. H. van der Velde
Ellen Kapiteijn
Alexander L. Vahrmeijer
机构：
[1] Leiden University Medical Centre,Department of Surgery
[2] Leiden University Medical Centre,Department of Radiology
[3] Leiden University Medical Centre,Department of Anesthesiology
[4] Leiden University Medical Centre,Department of Cardio
[5] Leiden University Medical Centre,Thoracic Surgery
来源：
CardioVascular and Interventional Radiology | 2017年 / 40卷
关键词：
Cancer; Liver; Uveal melanoma; Colorectal cancer; Interventional oncology; Chemoembolisation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1196 / 1205
页数：9
相关论文
共 8 条
  • [1] Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan
    de Leede, Eleonora M.
    Burgmans, Mark C.
    Meijer, T. Susanna
    Martini, Christian H.
    Tijl, Fred G. J.
    Vuyk, Jaap
    van Erkel, Arian R.
    van der Velde, Cornelis J. H.
    Kapiteijn, Ellen
    Vahrmeijer, Alexander L.
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2017, 40 (08) : 1196 - 1205
  • [2] Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan
    Eleonora M. de Leede
    Mark C. Burgmans
    T. Susanna Meijer
    Christian H. Martini
    Fred G. J. Tijl
    Jaap Vuyk
    Arian R. van Erkel
    Cornelis J. H. van der Velde
    Ellen Kapiteijn
    Alexander L. Vahrmeijer
    [J]. CardioVascular and Interventional Radiology, 2017, 40 : 1966 - 1966
  • [3] Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan (vol 40, pg 1196, 2017)
    de Leede, Eleonora M.
    Burgmans, Mark C.
    Meijer, T. Susanna
    Martini, Christian H.
    Tijl, Fred G. J.
    Vuyk, Jaap
    van Erkel, Arian R.
    van der Velde, Cornelis J. H.
    Kapiteijn, Ellen
    Vahrmeijer, Alexander L.
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2017, 40 (12) : 1966 - 1966
  • [4] Evaluation of Delcath Systems' Generation 2 (GEN 2) Melphalan Hemofiltration System in a Porcine Model of Percutaneous Hepatic Perfusion
    Moeslein, Fred M.
    McAndrew, Elizabeth G.
    Appling, William M.
    Hryniewich, Nicole E.
    Jarvis, Kevin D.
    Markos, Steven M.
    Sheets, Timothy P.
    Uzgare, Rajneesh P.
    Johnston, Daniel S.
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2014, 37 (03) : 763 - 769
  • [5] Evaluation of Delcath Systems’ Generation 2 (GEN 2) Melphalan Hemofiltration System in a Porcine Model of Percutaneous Hepatic Perfusion
    Fred M. Moeslein
    Elizabeth G. McAndrew
    William M. Appling
    Nicole E. Hryniewich
    Kevin D. Jarvis
    Steven M. Markos
    Timothy P. Sheets
    Rajneesh P. Uzgare
    Daniel S. Johnston
    [J]. CardioVascular and Interventional Radiology, 2014, 37 : 763 - 769
  • [6] Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems’ Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial
    T. Susanna Meijer
    Mark C. Burgmans
    Marta Fiocco
    Lioe-Fee de Geus-Oei
    Ellen Kapiteijn
    Eleonora M. de Leede
    Christian H. Martini
    Rutger W. van der Meer
    Fred G. J. Tijl
    Alexander L. Vahrmeijer
    [J]. CardioVascular and Interventional Radiology, 2019, 42 : 841 - 852
  • [7] Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial
    Meijer, T. Susanna
    Burgmans, Mark C.
    Fiocco, Marta
    de Geus-Oei, Lioe-Fee
    Kapiteijn, Ellen
    de Leede, Eleonora M.
    Martini, Christian H.
    van der Meer, Rutger W.
    Tijl, Fred G. J.
    Vahrmeijer, Alexander L.
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 42 (06) : 841 - 852
  • [8] Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents Pooled Analysis From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials
    Claessen, Bimmer E.
    Smits, Pieter C.
    Kereiakes, Dean J.
    Parise, Helen
    Fahy, Martin
    Kedhi, Elvin
    Serruys, Patrick W.
    Lansky, Alexandra J.
    Cristea, Ecaterina
    Sudhir, Krishnankutty
    Sood, Poornima
    Simonton, Charles A.
    Stone, Gregg W.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (11) : 1209 - 1215
1